Search
Patexia Research
Case number 2023-1805

United Therapeutics Corporation v. Liquidia Technologies, Inc. > Documents

Date Field Doc. No.Description (Pages)
Jun 13, 2024 65 Petition for writ of certiorari filed on 06/10/2024 in the U.S. Supreme Court. No.: 23-1298, United Therapeutics Corporation v. Inc. Liquidia Technologies. [1010959] [MVH] [Entered: 06/13/2024 03:33 PM] (1)
Mar 19, 2024 64 Mandate issued to the United States Patent and Trademark Office. Service as of this date by the Clerk of Court. [991462] [MVH] [Entered: 03/19/2024 10:30 AM] (1)
Mar 12, 2024 63 ORDER filed denying [54] petition for panel rehearing; rehearing en banc filed by United Therapeutics Corporation. By: Per Curiam. Service as of this date by the Clerk of Court. [990037] [MVH] [Entered: 03/12/2024 11:18 AM] (2)
Mar 6, 2024 62 ORDER filed denying [59] motion to file a response/reply filed by United Therapeutics Corporation. By: Per Curiam. Service as of this date by the Clerk of Court. [988732] [MVH] [Entered: 03/06/2024 01:57 PM] (2)
Mar 4, 2024 61 RESPONSE of Appellee Liquidia Technologies, Inc. to Doc No. [59]. Service: 03/04/2024 by email. [988099] [23-1805] [Sanya Sukduang] [Entered: 03/04/2024 02:14 PM] (8)
Mar 4, 2024 60 Amended Certificate of Interest for Appellee Liquidia Technologies, Inc.. Service: 03/04/2024 by email. [988098] [23-1805] [Sanya Sukduang] [Entered: 03/04/2024 02:11 PM] (3)
Mar 1, 2024 59 MOTION of Appellant United Therapeutics Corporation for leave to file a response/reply to Doc. No. [57]. Service: 03/01/2024 by email. [987956] [23-1805] [Douglas Carsten] [Entered: 03/01/2024 10:56 PM] (26)
Feb 28, 2024 58 13 paper copies of Doc. No. [57] received from Appellee Liquidia Technologies, Inc.. [987211] [VDW] [Entered: 02/28/2024 01:16 PM] (0)
Feb 26, 2024 57 RESPONSE of Appellee Liquidia Technologies, Inc. to Doc No. [54], [54]. Service: 02/26/2024 by email. [986568] [23-1805] [Sanya Sukduang] [Entered: 02/26/2024 04:03 PM] (26)
Feb 16, 2024 56 The court invites a response from Appellee Liquidia Technologies, Inc. to the petition [54]. Response due 03/01/2024. Service as of this date by the Clerk of Court. [984546] [MVH] [Entered: 02/16/2024 12:50 PM] (1)
Jan 23, 2024 55 16 paper copies of Doc. No. [54] received from Appellant United Therapeutics Corporation. [979238] [VDW] [Entered: 01/25/2024 11:21 AM] (0)
Jan 19, 2024 54 Petition for en banc rehearing, for panel rehearing filed by Appellant United Therapeutics Corporation. Service: 01/19/2024 by email. [977951] [23-1805] [Douglas Carsten] [Entered: 01/19/2024 08:59 PM] (42)
Dec 24, 2023 0 UNITED THERAPEUTICS CORPORATION v. LIQUIDIA TECHNOLOGIES, INC. [OPINION] [nonprecedential] (0)
Dec 20, 2023 53 JUDGMENT. AFFIRMED. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. Service as of this date by the Clerk of Court. [971699] [MVH] [Entered: 12/20/2023 09:47 AM] (1)
Dec 20, 2023 52 OPINION filed for the court by Lourie, Circuit Judge; Prost, Circuit Judge and Reyna, Circuit Judge. Nonprecedential Opinion. Service as of this date by the Clerk of Court. [971697] [MVH] [Entered: 12/20/2023 09:44 AM] (13)
Dec 4, 2023 51 Submitted after ORAL ARGUMENT to Panel: Lourie, Circuit Judge; Prost, Circuit Judge and Reyna, Circuit Judge.Arguing counsel: Douglas H. Carsten for United Therapeutics Corporation and Sanya Sukduang for Liquidia Technologies, Inc.Oral Argument Audio available here. [967413] [MJL] [Entered: 12/04/2023 02:59 PM] (0)
Nov 6, 2023 49 6 paper copies of Doc. No. [45] received from Appellee Liquidia Technologies, Inc.. [962030] [VDW] [Entered: 11/07/2023 03:23 PM] (0)
Nov 6, 2023 50 6 paper copies of Doc. No. [48] received from Appellant United Therapeutics Corporation. [962031] [VDW] [Entered: 11/07/2023 03:25 PM] (0)
Nov 2, 2023 48 MODIFIED ENTRY: CORRECTED REPLY BRIEF FILED by Appellant United Therapeutics Corporation. Service: 11/02/2023 by email. Paper copies of this brief must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(3)(A). [961092]--[Edited 11/03/2023 by MVH - Reason: compliance review complete] [Douglas Carsten] [Entered: 11/02/2023 09:45 PM] (46)
Nov 2, 2023 47 Notice of Correction to Doc No. [29] for Appellant United Therapeutics Corporation. Service: 11/02/2023 by email. [961091] [23-1805] [Douglas Carsten] [Entered: 11/02/2023 09:43 PM] (4)
Nov 1, 2023 46 Notice of Correction to Doc No. [45] for Appellee Liquidia Technologies, Inc.. Service: 11/01/2023 by email. [960753] [23-1805] [Sanya Sukduang] [Entered: 11/01/2023 04:26 PM] (7)
Nov 1, 2023 45 MODIFIED ENTRY: CORRECTED RESPONSE BRIEF FILED by Appellee Liquidia Technologies, Inc.. Service: 11/01/2023 by email. Paper copies of this brief must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(3)(A). [960750]--[Edited 11/02/2023 by MVH - Reason: compliance review complete] [Sanya Sukduang] [Entered: 11/01/2023 04:25 PM] (75)
Oct 24, 2023 44 6 paper copies of Doc. No. [39] received from Appellant United Therapeutics Corporation. (Night Box). [958803] [VDW] [Entered: 10/25/2023 11:23 AM] (0)
Oct 24, 2023 43 ORDER filed granting motion to correct/supplement [38] filed by Appellant United Therapeutics Corporation. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [958592] [MVH] [Entered: 10/24/2023 02:50 PM] (2)
Oct 23, 2023 42 Response to notice of oral argument from Appellant United Therapeutics Corporation. Service: 10/23/2023 by email. [958343] [23-1805] [Douglas Carsten] [Entered: 10/23/2023 04:13 PM] (1)
Oct 23, 2023 41 Response to notice of oral argument from Appellee Liquidia Technologies, Inc.. Service: 10/23/2023 by email. [958260] [23-1805] [Sanya Sukduang] [Entered: 10/23/2023 02:01 PM] (1)
Oct 20, 2023 40 6 paper copies of Doc. No. [30], [29] received from Appellant United Therapeutics Corporation. (Night Box). [958182] [VDW] [Entered: 10/23/2023 11:34 AM] (0)
Oct 20, 2023 39 MODIFIED ENTRY: CORRECTED OPENING BRIEF FILED by Appellant United Therapeutics Corporation. Service: 10/20/2023 by email. Paper copies of this brief must be submitted within five business days from the date of issuance of this notice. [958047]--[Edited 10/24/2023 by MVH - Reason: compliance review complete] [Douglas Carsten] [Entered: 10/20/2023 04:38 PM] (176)
Oct 20, 2023 38 MOTION of Appellant United Therapeutics Corporation to correct or supplement Opening Brief [17]. Service: 10/20/2023 by email. [958046] [23-1805] [Douglas Carsten] [Entered: 10/20/2023 04:33 PM] (9)
Oct 20, 2023 37 NOTICE OF ORAL ARGUMENT. Panel: 2312C. Case scheduled December 4, 2023. Response to Notice of Oral Argument due: 11/03/2023. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. Service as of this date by the Clerk of Court. [957937] [JCP] [Entered: 10/20/2023 02:02 PM] (2)
Oct 20, 2023 36 Notice to United Therapeutics Corporation: The record of this case indicates that paper copies of the reply brief [29] and confidential appendix [30] have not been provided pursuant to FCR 25(c)(3) (see Order No. [27]). Failure to file required documents may result in dismissal or other action as deemed appropriate by the court. See FCR 25(h). Service as of this date by the Clerk of Court. [957775] [MJL] [Entered: 10/20/2023 09:16 AM] (0)
Oct 18, 2023 35 Certificate of Compliance with Fed. Cir. R. 25.1(c)(2) for Appellee Liquidia Technologies, Inc.. Service: 10/18/2023 by email. [957435] [23-1805] [Sanya Sukduang] [Entered: 10/18/2023 06:35 PM] (3)
Oct 18, 2023 34 Certificate of Compliance with Fed. Cir. R. 25.1(c)(2) for Appellant United Therapeutics Corporation. Service: 10/18/2023 by email. [957431] [23-1805] [Douglas Carsten] [Entered: 10/18/2023 05:49 PM] (3)
Oct 16, 2023 33 6 paper copies of Doc. No. [21] received from Appellee Liquidia Technologies, Inc.. [956708] [VDW] [Entered: 10/16/2023 03:44 PM] (0)
Oct 16, 2023 32 6 paper copies of Doc. No. [17] received from Appellant United Therapeutics Corporation. [956704] [VDW] [Entered: 10/16/2023 03:41 PM] (0)
Oct 12, 2023 31 MODIFIED ENTRY: APPENDIX FILED by Appellant United Therapeutics Corporation. Service: 10/12/2023 by email. [956065] --[Edited 10/13/2023 by CAB - compliance review complete] [Douglas Carsten] [Entered: 10/12/2023 11:51 PM] (1549)
Oct 12, 2023 30 MODIFIED ENTRY: CONFIDENTIAL APPENDIX FILED by Appellant United Therapeutics Corporation. Service: 10/12/2023 by email. [956064]--[Edited 10/13/2023 by CAB - compliance review complete] [Douglas Carsten] [Entered: 10/12/2023 11:43 PM] (0)
Oct 11, 2023 29 MODIFIED ENTRY: REPLY BRIEF FILED by Appellant United Therapeutics Corporation. Service: 10/11/2023 by email. [955742] --[Edited 10/13/2023 by CAB - compliance review complete]. This document has been corrected. See Doc. No. [48] [Douglas Carsten] [Entered: 10/11/2023 10:25 PM] (46)
Sep 22, 2023 28 ORDER Within three business days of the date of filing of the joint appendix, United Therapeutics Corporation is directed to file six paper copies of its opening brief and Liquidia Technologies, Inc. is directed to file six paper copies of its response brief. Service as of this date by the Clerk of Court. [951913] [LMS] [Entered: 09/22/2023 02:20 PM] (2)
Sep 21, 2023 27 ORDER filed granting the motion to extend time [23] to the extent that United Therapeutics Corporation's reply brief is due no later than October 11, 2023, and the joint appendix is due no later than October 12, 2023. United Therapeutics Corporation shall file six paper copies of its reply brief and the joint appendix within three business days after the court completes its compliance review of each of the documents. Service as of this date by the Clerk of Court. [951550] [LMS] [Entered: 09/21/2023 02:19 PM] (2)
Sep 20, 2023 26 REPLY of Appellant United Therapeutics Corporation to response [24]. Service: 09/20/2023 by email. [951247] [23-1805] [Douglas Carsten] [Entered: 09/20/2023 12:07 PM] (10)
Sep 19, 2023 25 **TEXT ONLY** ORDER granting motion to withdraw attorney Deepa Kannappan [22] filed by Appellee Liquidia Technologies, Inc.. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [951045] [CAB] [Entered: 09/19/2023 02:36 PM] (0)
Sep 18, 2023 24 RESPONSE of Appellee Liquidia Technologies, Inc. to Doc No. [23]. Service: 09/18/2023 by email. [950792] [23-1805] [Sanya Sukduang] [Entered: 09/18/2023 06:20 PM] (136)
Sep 18, 2023 23 MOTION of Appellant United Therapeutics Corporation to extend the time to 10/11/2023 to file brief. Service: 09/18/2023 by email. [950671] [23-1805] [Douglas Carsten] [Entered: 09/18/2023 01:39 PM] (8)
Sep 14, 2023 22 MOTION of Appellee Liquidia Technologies, Inc. to withdraw counsel Deepa Kannappan. Service: 09/14/2023 by email. [950044] [23-1805] [Sanya Sukduang] [Entered: 09/14/2023 02:12 PM] (7)
Sep 6, 2023 21 MODIFIED ENTRY: RESPONSE BRIEF FILED by Appellee Liquidia Technologies, Inc.. Service: 09/06/2023 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [948056] --[Edited 09/13/2023 by CAB - compliance review complete]. This document has been corrected. See Doc. No. [45] [Sanya Sukduang] [Entered: 09/06/2023 01:51 PM] (75)
Sep 6, 2023 20 Entry of Appearance for Brittany Cazakoff as counsel for Appellee Liquidia Technologies, Inc.. Service: 09/06/2023 by email. [947951] [23-1805] [Brittany Cazakoff] [Entered: 09/06/2023 11:03 AM] (1)
Aug 18, 2023 19 Filing fee paid. Fee Amount: $500.00. Receipt Number: A13-39751-912. [944323] [23-1805] [Douglas Carsten] [Entered: 08/18/2023 03:35 PM] (0)
Aug 18, 2023 18 Notice to Appellant United Therapeutics Corporation: The record of this case indicates that no fee payment for the appeal under FCR 52(a)(1) has been paid. Failure to file required documents may result in dismissal or other action as deemed appropriate by the court. See FCR 25(h). Service as of this date by the Clerk of Court. [944284] [CAB] [Entered: 08/18/2023 02:05 PM] (0)
Aug 4, 2023 17 MODIFIED ENTRY: OPENING BRIEF FILED by Appellant United Therapeutics Corporation. Service: 08/04/2023 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [940896] --[Edited 08/21/2023 by ALK - compliance review complete] [Douglas Carsten] [Entered: 08/04/2023 11:04 PM] (179)
Aug 4, 2023 16 Certificate of Interest for Appellant United Therapeutics Corporation. Service: 08/04/2023 by email. [940892] [23-1805] [Douglas Carsten] [Entered: 08/04/2023 09:09 PM] (3)
Jun 16, 2023 15 ORDER filed granting the motion [10] only to the extent that the case will be placed on the next available oral argument calendar after briefing is complete. Service as of this date by the Clerk of Court. [930692] [LMS] [Entered: 06/16/2023 02:42 PM] (2)
Jun 9, 2023 14 Certified list received. Service: 06/05/2023 by email. Refer to Fed. Cir. R. 31 for calculating brief deadlines from service of the certified list. [928922] [MMA] [Entered: 06/09/2023 10:24 AM] (78)
Jun 2, 2023 13 REPLY of Appellee Liquidia Technologies, Inc. to response [12]. Service: 06/02/2023 by email. [927556] [23-1805] [Sanya Sukduang] [Entered: 06/02/2023 05:09 PM] (250)
May 30, 2023 12 RESPONSE of Appellant United Therapeutics Corporation to Doc No. [10], [10]. Service: 05/30/2023 by email. [926690] [23-1805] [Douglas Carsten] [Entered: 05/30/2023 09:36 PM] (133)
May 23, 2023 11 ORDER directing UTC to respond to the motion [10] no later than seven days from the date of filing of this order. Any reply is due no later than three days thereafter. Service as of this date by the Clerk of Court. [925310] [LMS] [Entered: 05/23/2023 01:26 PM] (2)
May 22, 2023 10 MOTION of Appellee Liquidia Technologies, Inc. to expedite briefing schedule, to expedite hearing. Service: 05/22/2023 by email. [925127] [23-1805] [Sanya Sukduang] [Entered: 05/22/2023 04:55 PM] (441)
May 10, 2023 9 Notice of Related Case Information for Appellant United Therapeutics Corporation. Service: 05/10/2023 by email. [922706] [23-1805] [Douglas Carsten] [Entered: 05/10/2023 09:11 PM] (3)
May 10, 2023 8 Certificate of Interest for Appellant United Therapeutics Corporation. Service: 05/10/2023 by email. [922705] [23-1805] [Douglas Carsten] [Entered: 05/10/2023 09:07 PM] (3)
May 10, 2023 7 Entry of Appearance for Douglas H. Carsten; Shaun R. Snader; Adam Burrowbridge; Arthur P. Dykhuis; William Jackson as counsel for Appellant United Therapeutics Corporation. Service: 05/10/2023 by email. [922704] [23-1805] [Douglas Carsten] [Entered: 05/10/2023 09:05 PM] (2)
May 10, 2023 6 Docketing Statement for the Appellant United Therapeutics Corporation. Service: 05/10/2023 by email. [922702] [23-1805] [Douglas Carsten] [Entered: 05/10/2023 08:50 PM] (2)
May 10, 2023 5 Notice of Related Case Information for Appellee Liquidia Technologies, Inc.. Service: 05/10/2023 by email. [922496] [23-1805] [Sanya Sukduang] [Entered: 05/10/2023 12:27 PM] (3)
May 10, 2023 4 Docketing Statement for the Appellee Liquidia Technologies, Inc.. Service: 05/10/2023 by email. [922493] [23-1805] [Sanya Sukduang] [Entered: 05/10/2023 12:25 PM] (2)
May 10, 2023 3 Certificate of Interest for Appellee Liquidia Technologies, Inc.. Service: 05/10/2023 by email. [922492] [23-1805] [Sanya Sukduang] [Entered: 05/10/2023 12:23 PM] (3)
May 10, 2023 2 Entry of Appearance for Sanya Sukduang; Jonathan R. Davies; Deepa Kannappan as counsel for Appellee Liquidia Technologies, Inc.. Service: 05/10/2023 by email. [922489] [23-1805] [Sanya Sukduang] [Entered: 05/10/2023 12:20 PM] (2)
Apr 26, 2023 1 Appeal docketed. Received: 04/05/2023. [919369] Entry of Appearance is due on 05/10/2023. Certificate of Interest is due on 05/10/2023. Docketing Statement is due on 05/10/2023. Certified List is due on 06/05/2023. [CMH] [Entered: 04/26/2023 04:41 PM] (0)
Menu